SpringWorks Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

SpringWorks Therapeutics (SWTX), a commercial-stage biopharmaceutical company specializing in severe rare diseases and cancer, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Chief Executive Officer Saqib Islam will deliver a presentation on Monday, January 13, 2025, at 11:15 a.m. PT.

The presentation will be accessible via live webcast through the Events & Presentations page in the Investors & Media section of SpringWorks' website. Interested parties can view a replay of the presentation for a time following the conference through the company's website at ir.springworkstx.com.

STAMFORD, Conn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 11:15 a.m. PT.

To access the live webcast, please visit the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the conference.

About SpringWorks Therapeutics

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. OGSIVEO^® (nirogacestat), approved in the United States for the treatment of adult patients with progressing desmoid tumors who require systemic treatment, is the Company’s first FDA-approved therapy. SpringWorks also has a diversified targeted therapy pipeline spanning solid tumors and hematological cancers, with programs ranging from preclinical development through advanced clinical trials. In addition to its wholly owned programs, SpringWorks has also entered into multiple collaborations with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients in need.

For more information, visit www.springworkstx.com and follow @SpringWorksTx on X (formerly Twitter), LinkedIn, and YouTube.

Contacts:
Investors
investors@springworkstx.com

Media
media@springworkstx.com

FAQ

When is SpringWorks Therapeutics (SWTX) presenting at the J.P. Morgan Healthcare Conference 2025?

SpringWorks Therapeutics will present at the conference on Monday, January 13, 2025, at 11:15 a.m. PT.

How can investors watch SpringWorks Therapeutics' (SWTX) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation via live webcast through the Events & Presentations page within the Investors & Media section of SpringWorks' website at ir.springworkstx.com.

Will there be a replay available of SpringWorks Therapeutics' (SWTX) J.P. Morgan presentation?

Yes, a replay of the webcast will be available on SpringWorks' website for a time following the conference.

What therapeutic areas does SpringWorks Therapeutics (SWTX) focus on?

SpringWorks Therapeutics focuses on severe rare diseases and cancer as their primary therapeutic areas.